miRNA‑490‑3p promotes the metastatic progression of invasive ductal carcinoma - Lu, Ning; Zhang, Mei; Lu, Lu; Liu, Yan‑Zhao; Zhang, Hai‑Hong; Liu, Xiao‑Dong (Oncology reports, 2021)
Keywords: Animals; Antibodies; Binding sites; Breast - pathology; Breast - surgery; Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - mortality; Breast Neoplasms - pathology; Breast Neoplasms - surgery; Cancer therapies; Carcinoma, Ductal; Carcinoma, Ductal, Breast - genetics; Carcinoma, Ductal, Breast - mortality; Carcinoma, Ductal, Breast - secondary; Carcinoma, Ductal, Breast - surgery; Cell growth; Cell Line, Tumor; Chemotherapy; Comparative analysis; Disease Progression; Disease-Free Survival; DNA-Binding Proteins - genetics; Epithelial-Mesenchymal Transition - genetics; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Instrument industry; Labeling; Lung cancer; Mastectomy; Metastasis; Mice; MicroRNA; MicroRNAs; MicroRNAs - genetics; MicroRNAs - metabolism; Neoplasm Recurrence, Local - epidemiology; Neoplasm Recurrence, Local - genetics; Plasmids; Protein binding; Proteins; Reagents; RNA-Binding Proteins - genetics; Scientific equipment and supplies industry; Transforming growth factors; Xenograft Model Antitumor Assays; United States; China; miR‑490‑3p; epithelial‑to‑mesenchymal transition; breast cancer; poly r(C) binding protein 1